Multidrug resistance reversing activity of newly developed phenothiazines on P-glycoprotein (ABCB1)-related resistance of mouse T-lymphoma cells

Anticancer Research

Volumn 34, Issue 4, 2014, Pages 1737-1742

  Spengler, Gabriella ^a   Takács, Daniella ^b   Horváth, Ádám ^a   Riedl, Zsuzsanna ^b   Hajós, György ^b   Amaral, Leonard ^c   Molnár, József ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

Author keywords

ABCB1; ATP binding cassette protein B1; Ethidium bromide; Mouse T lymphoma cell lines; Multidrug resistance; P glycoprotein; Phenothiazines; Rhodamine 123; Thioridazine; Verapamil

Indexed keywords

ETHIDIUM BROMIDE; PHENOTHIAZINE DERIVATIVE; RHODAMINE 123; THIORIDAZINE; VERAPAMIL; ANTINEOPLASTIC AGENT; MULTIDRUG RESISTANCE PROTEIN; PHENOTHIAZINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RESISTANCE; CELL PROLIFERATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; LYMPHOMA; LYMPHOMA CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; T LYMPHOMA; ABCB1; ANIMAL; ATP-BINDING CASSETTE PROTEIN B1; CHEMISTRY; DRUG EFFECT; DRUG RESISTANCE; GENE EXPRESSION; GENETICS; METABOLISM; MOUSE T-LYMPHOMA CELL LINES; MULTIDRUG RESISTANCE; T CELL LYMPHOMA; TUMOR CELL LINE;

ABCB1; ATP-BINDING CASSETTE PROTEIN B1; ETHIDIUM BROMIDE; MOUSE T-LYMPHOMA CELL LINES; MULTIDRUG RESISTANCE; P-GLYCOPROTEIN; PHENOTHIAZINES; RHODAMINE 123; THIORIDAZINE; VERAPAMIL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; LYMPHOMA, T-CELL; MICE; P-GLYCOPROTEINS; PHENOTHIAZINES; RHODAMINE 123;

EID: 84902265726     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kristiansen JE and Amaral L: The potential management of resistant infections with non-antibiotics. J Antimicrob Chemother 40: 319-327, 1997.
2. Martins M, Schelz Z, Martins A, Molnar J, Hajós G, Riedl Z, Viveiros M, Yalcin I, Aki-Sener E and Amaral L: In vitro and ex vivo activity of thioridazine derivatives against Mycobacterium tuberculosis. Int J Antimicrob Agents 29(3): 338-340, 2007.
3. Motohashi N, Sakagami H, Kurihara T, Csuri K and Molnar J: Antiplasmid activity of phenothiazines, benzo[a]phenothiazines and benz[c]acridines. Anticancer Res 12(1): 135-139, 1992.
4. Molnar J, Mandi Y, Petri I, Petofi S, Sakagami H, Kurihara T and Motohashi N: Immunomodulation activity of phenothiazines, benzo[a]phenothiazines and benz[c]acridines. Anticancer Res 13 (2): 439-442, 1993.
5. Motohashi N, Kurihara T, Satoh K, Sakagami H, Mucsi I, Pusztai R, Szabó M and Molnár J: Antitumor activity of benzo[a] phenothiazines. Anticancer Res 19(3A): 1837-1842, 1999.
6. Gupta RR and Kumar M: Synthesis, properties and reactions of phenothiazines. In: Phenothiazines and 1,4-Benzothiazines -Chemical and Biological Aspects. Gupta RR (ed.). Elsevier, Amsterdam, pp. 1-161, 1988.
7. Pluta K, Morak-Mlodawska B and Jeleñ M: Recent progress in biological activities of synthesized phenothiazines. Eur J Med Chem 46(8): 3179-3189, 2011.
8. Ohlow MJ and Moosmann B: Phenothiazine: The seven lives of pharmacology's first lead structure. Drug Discov Today 16(3-4): 119-131, 2011.
9. Takács D, Cerca P, Martins A, Riedl Z, Hajós G, Molnár J, Viveiros M, Couto I and Amaral L: Evaluation of 40 new phenothiazine derivatives for activity against intrinsic efflux pump systems of reference Escherichia coli, Salmonella Enteritidis, Enterococcus faecalis and Staphylococcus aureus strains. In Vivo 25(5): 719-724, 2011.
10. Lee CH: Reversing agents for ATP-binding cassette drug transporters. Methods Mol Biol 596: 325-340, 2010.
11. Jaszczyszyn A, Gąsiorowski K K, ͆wiątek P, Malinka W, Ciëlik-Boczula K, Petrus J and Czarnik-Matusewicz B: Chemical structure of phenothiazines and their biological activity. Pharmacol Rep 64(1): 16-23, 2012.
12. Takács D, Bombicz P, Egyed O, Drahos L, Jemnitz K, Visy J, Molnár J, Riedl Z and Hajós G: Synthesis and pharmacological investigation of new 2-amino-N -hydroxyalkylphenothiazines exhibiting marked MDR-inhibitory effect. Bioorg Med Chem 21: 3760-3779, 2013.
13. Takács D, Nagy I, Bombicz P, Egyed O, Jemnitz K, Riedl Z, Molnár J, Amaral L and Hajós G: Selective hydroboration of dieneamines. Formation of hydroxyalkylphenothiazines as MDR modulators. Bioorg Med Chem 20(14): 4258-4270, 2012.
14. Pastan I, Gottesman, MM, Ueda K, Lovelace E, Rutherford AV and Willingham MC: A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc Natl Acad Sci USA 85: 4486-4490, 1988.
15. Choi K, Frommel TO, Stern RK, Perez CF, Kriegler M, Tsuruo T and Roninson IB: Multidrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection. Proc Natl Acad Sci USA 88: 7386-7390, 1991.
16. Gyemant N, Tanaka M, Molnar P, Deli J, Mandoky L and Molnar J: Reversal of multidrug resistance of cancer cells in vitro: modification of drug resistance by selected carotenoids. Anticancer Res 26: 367-374, 2006.
17. Orlowski S, Mir LM, Belehradek J Jr. and Garrigos M: Effects of steroids and verapamil on P-glycoprotein ATPase activity: Progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators. Biochem J 317(Pt 2): 515-522, 1996.
18. Spengler G, Viveiros M, Martins M, Rodrigues L, Molnar J, Couto I and Amaral L: Demonstration of the activity of P-glycoprotein by a semi-automated fluorometric method. Anticancer Res 29: 2173-2177, 2009.
19. Wuonola MA, Palfreyman MG, Motohashi N, Kawase M, Gabay S, Gupta RR and Molnár J: The primary in vitro anticancer activity of 'half-mustard type' phenothiazines in NCI's revised anticancer screening paradigm. Anticancer Res 18: 337-348, 1998.
20. Bisi A, Meli M, Gobbi S, Rampa A, Tolomeo M and Dusonchet L: Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives. Bioorg Med Chem 16: 6474-6482, 2008.